Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorina Veliceasa

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
PPAR Research|December 2, 2008
PPARgamma and Agonists against Cancer: Rational Design of Complementation TreatmentsDorina Veliceasa, Frank Thilo Schulze-Hoëpfner, Olga V Volpert
Expert Opinion on Drug Discovery|May 7, 2013
The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Susan E Craword, Philip Fitchev, Dorina Veliceasa, et al.
Plos One|January 7, 2014
miR-200b inhibits prostate cancer EMT, growth and metastasisLaTanya V Williams, Dorina Veliceasa, Elena Vinokour, et al.
Plos One|March 10, 2012
Androgen receptor drives cellular senescenceYelena Mirochnik, Dorina Veliceasa, Latanya Williams, et al.
The Journal of Biological Chemistry|February 27, 2010
Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma)Dauren Biyashev, Dorina Veliceasa, Angela Kwiatek, et al.
Vascular Cell|July 11, 2015
Therapeutic manipulation of angiogenesis with miR-27bDorina Veliceasa, Dauren Biyashev, Gangjian Qin, et al.
The FEBS Journal|November 21, 2007
Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinomaDorina Veliceasa, Marina Ivanovic, Frank Thilo-Schulze Hoepfner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategyRonald Yap, Dorina Veliceasa, Urban Emmenegger, et al.
Virus Genes|April 11, 2006
Searching for a new putative cryptic virus in Pinus sylvestris LDorina Veliceasa, Natalya Enünlü, Péter B Kós, et al.
Acta Biomaterialia|January 19, 2016
Sonic hedgehog delivery from self-assembled nanofiber hydrogels reduces the fibrotic response in models of erectile dysfunctionShawn Choe, Dorina Veliceasa, Christopher W Bond, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
PPAR Research|December 2, 2008
PPARgamma and Agonists against Cancer: Rational Design of Complementation TreatmentsDorina Veliceasa, Frank Thilo Schulze-Hoëpfner, Olga V Volpert
Expert Opinion on Drug Discovery|May 7, 2013
The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Susan E Craword, Philip Fitchev, Dorina Veliceasa, et al.
Plos One|January 7, 2014
miR-200b inhibits prostate cancer EMT, growth and metastasisLaTanya V Williams, Dorina Veliceasa, Elena Vinokour, et al.
Plos One|March 10, 2012
Androgen receptor drives cellular senescenceYelena Mirochnik, Dorina Veliceasa, Latanya Williams, et al.
The Journal of Biological Chemistry|February 27, 2010
Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma)Dauren Biyashev, Dorina Veliceasa, Angela Kwiatek, et al.
Vascular Cell|July 11, 2015
Therapeutic manipulation of angiogenesis with miR-27bDorina Veliceasa, Dauren Biyashev, Gangjian Qin, et al.
The FEBS Journal|November 21, 2007
Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinomaDorina Veliceasa, Marina Ivanovic, Frank Thilo-Schulze Hoepfner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategyRonald Yap, Dorina Veliceasa, Urban Emmenegger, et al.
Virus Genes|April 11, 2006
Searching for a new putative cryptic virus in Pinus sylvestris LDorina Veliceasa, Natalya Enünlü, Péter B Kós, et al.
Acta Biomaterialia|January 19, 2016
Sonic hedgehog delivery from self-assembled nanofiber hydrogels reduces the fibrotic response in models of erectile dysfunctionShawn Choe, Dorina Veliceasa, Christopher W Bond, et al.
Pageof 3